SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Homozygous Missense Variants in NTNG2, Encoding a Presynaptic Netrin-G2 Adhesion Protein, Lead to a Distinct Neurodevelopmental Disorder.

Dias, CM; Punetha, J; Zheng, C; Mazaheri, N; Rad, A; Efthymiou, S; Petersen, A; Dehghani, M; Pehlivan, D; Partlow, JN; et al. Dias, CM; Punetha, J; Zheng, C; Mazaheri, N; Rad, A; Efthymiou, S; Petersen, A; Dehghani, M; Pehlivan, D; Partlow, JN; Posey, JE; Salpietro, V; Gezdirici, A; Malamiri, RA; Al Menabawy, NM; Selim, LA; Vahidi Mehrjardi, MY; Banu, S; Polla, DL; Yang, E; Rezazadeh Varaghchi, J; Mitani, T; van Beusekom, E; Najafi, M; Sedaghat, A; Keller-Ramey, J; Durham, L; Coban-Akdemir, Z; Karaca, E; Orlova, V; Schaeken, LLM; Sherafat, A; Jhangiani, SN; Stanley, V; Shariati, G; Galehdari, H; Gleeson, JG; Walsh, CA; Lupski, JR; Seiradake, E; Houlden, H; van Bokhoven, H; Maroofian, R (2019) Homozygous Missense Variants in NTNG2, Encoding a Presynaptic Netrin-G2 Adhesion Protein, Lead to a Distinct Neurodevelopmental Disorder. Am J Hum Genet, 105 (5). pp. 1048-1056. ISSN 1537-6605 https://doi.org/10.1016/j.ajhg.2019.09.025
SGUL Authors: Maroofian, Reza

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

NTNG2 encodes netrin-G2, a membrane-anchored protein implicated in the molecular organization of neuronal circuitry and synaptic organization and diversification in vertebrates. In this study, through a combination of exome sequencing and autozygosity mapping, we have identified 16 individuals (from seven unrelated families) with ultra-rare homozygous missense variants in NTNG2; these individuals present with shared features of a neurodevelopmental disorder consisting of global developmental delay, severe to profound intellectual disability, muscle weakness and abnormal tone, autistic features, behavioral abnormalities, and variable dysmorphisms. The variants disrupt highly conserved residues across the protein. Functional experiments, including in silico analysis of the protein structure, in vitro assessment of cell surface expression, and in vitro knockdown, revealed potential mechanisms of pathogenicity of the variants, including loss of protein function and decreased neurite outgrowth. Our data indicate that appropriate expression of NTNG2 plays an important role in neurotypical development.

Item Type: Article
Additional Information: © 2019 The Author(s). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Keywords: NTNG2, autism, developmental delay, intellectual disability, neurodevelopmental disorder, 06 Biological Sciences, 11 Medical And Health Sciences, Genetics & Heredity
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Am J Hum Genet
ISSN: 1537-6605
Language: eng
Dates:
DateEvent
7 November 2019Published
24 October 2019Published Online
25 September 2019Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
U54HG003067National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
UM1HG008900National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
U54HG006504National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
R35 NS105078National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
UM1HG006542National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
K08HG008986National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
R01NS048453National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
R01NS052455National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
T32 NS043124-17National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
R01NS035129National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
T32 MH112510National Institutes of Healthhttp://dx.doi.org/10.13039/100000002
512848Muscular Dystrophy Associationhttp://dx.doi.org/10.13039/100005202
202827/Z/16/ZWellcome Trusthttp://dx.doi.org/10.13039/100004440
165908Wellcome Trusthttp://dx.doi.org/10.13039/100004440
WT093205Wellcome Trusthttp://dx.doi.org/10.13039/100004440
WT104033AIAWellcome Trusthttp://dx.doi.org/10.13039/100004440
UNSPECIFIEDNational Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
UNSPECIFIEDRosetrees Trusthttp://dx.doi.org/10.13039/501100000833
UNSPECIFIEDAtaxia UKhttp://dx.doi.org/10.13039/501100000346
UNSPECIFIEDMSA TrustUNSPECIFIED
UNSPECIFIEDBrain Research UKUNSPECIFIED
UNSPECIFIEDMuscular Dystrophy UKUNSPECIFIED
UNSPECIFIEDHigher Education Commission of PakistanUNSPECIFIED
MR/S01165X/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MR/S005021/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
G0601943Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
241995Seventh Framework Programmehttp://dx.doi.org/10.13039/501100004963
99999.013311/2013-01CAPES FellowshipUNSPECIFIED
UNSPECIFIEDUehara Memorial FoundationUNSPECIFIED
UNSPECIFIEDBroad InstituteUNSPECIFIED
UNSPECIFIEDYale Center for Mendelian DisordersUNSPECIFIED
UNSPECIFIEDHarvard Center for Mendelian DisordersUNSPECIFIED
UNSPECIFIEDQueen Square Genomics GroupUNSPECIFIED
PubMed ID: 31668703
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/111422
Publisher's version: https://doi.org/10.1016/j.ajhg.2019.09.025

Actions (login required)

Edit Item Edit Item